Table 3.
Base-case results. OMA: omalizumab; incr: incremental; eff: effectiveness
| Strategy | Cost (¥) |
Incr Cost (¥) | Eff (QALY) | Incr Eff (QALY) | ICER (¥/QALY) |
|---|---|---|---|---|---|
| SoC | 30,850.87 | 6.06 | |||
| OMA | 56,053.51 | 25,202.65 | 6.22 | 0.16 | 160,411.52 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.